Jack L. Arbiser

791 total citations
10 papers, 645 citations indexed

About

Jack L. Arbiser is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jack L. Arbiser has authored 10 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jack L. Arbiser's work include Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Jack L. Arbiser is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Jack L. Arbiser collaborates with scholars based in United States, Australia and United Kingdom. Jack L. Arbiser's co-authors include Richard M. Rohan, H. Randolph Byers, Mou-Tuan Huang, Carolyn Fisher, Nancy Klauber, Raymond L. Barnhill, Junguk Park, Gunnar F. Kaufmann, Kim D. Janda and J. Phillip Bowen and has published in prestigious journals such as The Journal of Infectious Diseases, American Journal Of Pathology and Journal of the American Academy of Dermatology.

In The Last Decade

Jack L. Arbiser

9 papers receiving 621 citations

Peers

Jack L. Arbiser
Khaled Al‐Hussein Saudi Arabia
Xiaohua Rong United States
Rita Chakrabarti United States
Eun-Kyung Bae South Korea
Venugopal Chenna United States
Johng S. Rhim United States
Khaled Al‐Hussein Saudi Arabia
Jack L. Arbiser
Citations per year, relative to Jack L. Arbiser Jack L. Arbiser (= 1×) peers Khaled Al‐Hussein

Countries citing papers authored by Jack L. Arbiser

Since Specialization
Citations

This map shows the geographic impact of Jack L. Arbiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Arbiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Arbiser more than expected).

Fields of papers citing papers by Jack L. Arbiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Arbiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Arbiser. The network helps show where Jack L. Arbiser may publish in the future.

Co-authorship network of co-authors of Jack L. Arbiser

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. Arbiser. A scholar is included among the top collaborators of Jack L. Arbiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. Arbiser. Jack L. Arbiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Soff, Gerald A., Wolfgang Dubiel, Masuko Ushio‐Fukai, et al.. (2021). Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo. UNC Libraries.
2.
Park, Junguk, Gunnar F. Kaufmann, J. Phillip Bowen, Jack L. Arbiser, & Kim D. Janda. (2008). Solenopsin A, a Venom Alkaloid from the Fire AntSolenopsis invicta,Inhibits Quorum‐Sensing Signaling inPseudomonas aeruginosa. The Journal of Infectious Diseases. 198(8). 1198–1201. 53 indexed citations
3.
Kim, Amy, C. M. S. Cohen, Calvin O. McCall, et al.. (2001). Are keloids really “gli-loids”?: High-level expression of gli-1 oncogene in keloids. Journal of the American Academy of Dermatology. 45(5). 707–711. 39 indexed citations
4.
Arbiser, Jack L., Raymond S. Yeung, Sharon W. Weiss, et al.. (2001). The Generation and Characterization of a Cell Line Derived from a Sporadic Renal Angiomyolipoma. American Journal Of Pathology. 159(2). 483–491. 37 indexed citations
5.
Klafter, Robert & Jack L. Arbiser. (2000). Regulation of Angiogenesis and Tumorigenesis by Signal Transduction Cascades: Lessons from Benign and Malignant Endothelial Tumors. Journal of Investigative Dermatology Symposium Proceedings. 5(1). 79–82. 19 indexed citations
6.
LaMontagne, Kenneth R., Marsha A. Moses, Dmitri Wiederschain, et al.. (2000). Inhibition of MAP Kinase Kinase Causes Morphological Reversion and Dissociation between Soft Agar Growth and in Vivo Tumorigenesis in Angiosarcoma Cells. American Journal Of Pathology. 157(6). 1937–1945. 42 indexed citations
7.
Arbiser, Jack L., Gerhard Raab, Richard M. Rohan, et al.. (1999). Isolation of Mouse Stromal Cells Associated with a Human Tumor Using Differential Diphtheria Toxin Sensitivity. American Journal Of Pathology. 155(3). 723–729. 34 indexed citations
8.
Arbiser, Jack L., et al.. (1998). Analysis of vascularity of human neurofibromas. Journal of the American Academy of Dermatology. 38(6). 950–954. 45 indexed citations
9.
Arbiser, Jack L., Jo‐David Fine, Dédée F. Murrell, et al.. (1998). Basic Fibroblast Growth Factor: A Missing Link between Collagen VII, Increased Collagenase, and Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa. Molecular Medicine. 4(3). 191–195. 37 indexed citations
10.
Arbiser, Jack L., Nancy Klauber, Richard M. Rohan, et al.. (1998). Curcumin Is an In Vivo Inhibitor of Angiogenesis. Molecular Medicine. 4(6). 376–383. 339 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026